These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 20410527

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Personalized-medicine trials on the rise.
    Benowitz S.
    J Natl Cancer Inst; 2012 Oct 03; 104(19):1425-6. PubMed ID: 23008496
    [No Abstract] [Full Text] [Related]

  • 5. Progress towards personalized medicine.
    Bates S.
    Drug Discov Today; 2010 Feb 03; 15(3-4):115-20. PubMed ID: 19914397
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The search for optimal response prediction in cancer leads to a personalized approach.
    Van Cutsem E, Ciardiello F.
    Target Oncol; 2010 Mar 03; 5(1):3-4. PubMed ID: 20349283
    [No Abstract] [Full Text] [Related]

  • 12. Cancer biomarkers: current issues and future directions.
    Jain KK.
    Curr Opin Mol Ther; 2007 Dec 03; 9(6):563-71. PubMed ID: 18041667
    [Abstract] [Full Text] [Related]

  • 13. Making personalized cancer medicine a reality: challenges and opportunities in the development of biomarkers and companion diagnostics.
    Parkinson DR, Johnson BE, Sledge GW.
    Clin Cancer Res; 2012 Feb 01; 18(3):619-24. PubMed ID: 22298894
    [Abstract] [Full Text] [Related]

  • 14. Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care.
    Roukos DH.
    Expert Rev Mol Diagn; 2010 Jan 01; 10(1):33-48. PubMed ID: 20014921
    [Abstract] [Full Text] [Related]

  • 15. [Personalized treatment of cancer: utopia or chance?].
    Thiel E.
    Dtsch Med Wochenschr; 2010 Sep 01; 135(38):1851. PubMed ID: 20842603
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Genetic determinants of anticancer drug activity: towards a global approach to personalized cancer medicine.
    Picker A, Jackson DB.
    Expert Rev Mol Diagn; 2011 Jul 01; 11(6):567-77. PubMed ID: 21745011
    [Abstract] [Full Text] [Related]

  • 18. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.
    Workman P.
    Cancer Chemother Pharmacol; 2003 Jul 01; 52 Suppl 1():S45-56. PubMed ID: 12819933
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.